A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema.

@article{Kunschak1998ARC,
  title={A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema.},
  author={M Kunschak and Werner Engl and Friedrich Maritsch and Fred S. Rosen and Gerald Eder and Gerold Zerlauth and Hans Peter Schwarz},
  journal={Transfusion},
  year={1998},
  volume={38 6},
  pages={540-9}
}
BACKGROUND No effective treatment exists in the United States for acute attacks of hereditary angioedema (HAE). STUDY DESIGN AND METHODS To evaluate the efficacy and safety of C1 inhibitor concentrate in treating HAE, a large primary care and referral center hospital conducted a randomized, placebo-controlled, double-blind trial with intent-to-treat… CONTINUE READING